DUBLIN--(BUSINESS WIRE)--The "Middle East And Africa 3D Cell Culture Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.
The Middle East and Africa 3D cell culture market is set to grow with 12.82% of CAGR in the forecast period from 2019-2027.
Discovery Health Medical Scheme's research report reveals that in South Africa, more number of deaths are caused by cancer than by HIV/AIDS, malaria, and tuberculosis combined. In 2017, the percentage of new cancer cases increased by 10% from 2011. Cancer drug screening is thus an essential part of cancer drug discovery. Cell-based assays have a crucial role to play in anti-cancer drug screening. Besides, in 3D cultures, cells exhibit gene expression profiles that help their clinical efficacy. 3D cell culture systems are thus used extensively for anti-cancer drug screening, and this has driven the 3D cell culture market growth.
Moreover, a cord cell bank in South Africa named Netcells Biosciences, was reported to have banked cord blood stem cells for over 5000 patients. Another stem cell bank, Cryo-Save, launched a campaign in the country, with an aim to educate gynecologists about the benefits of stem cell preservation. 3D cell culture thus has various applications, owing to which an increasing demand for 3D cell culturing is expected in South Africa in the forecast period, which would thereby fuel the growth of the country's 3D cell culture market.
Becton Dickinson and Company, Merck KGaA, Thermo Fisher Scientific, Inc., PromoCell GmbH, GE Healthcare, VWR Corporation, and Corning, Inc. are the companies having a strong foothold in the 3D cell culture market.
Key Topics Covered:
1. Middle East And Africa 3D Cell Culture Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.3. Economic Technological, And Political & Legal Outlook
2.4. Regulatory Market
2.5. Key Insight
2.6. Market Attractiveness Index
2.7. Market Drivers
2.7.1. Growing Cancer Prevalence
2.7.2. High Demand For Organ Transplantation
2.7.3. Promising Developments Using Regenerative Medicine
2.8. Market Restraints
2.8.1. Lack Of Skilled Professionals
2.8.2. Incompatibilities Of The Preferred Analytical Technologies With 3D Cell Culture
2.9. Market Opportunities
2.9.1. Increasing Usage Of 3D Cell Culture In Organ Transplantation And Drug Screening
2.9.2. Technological Advancement
2.10. Market Challenges
2.10.1. Lack Of Availability Of Data For Research On 3D Cell Culture
2.10.2. Challenges Associated With 3D Cell Culture In Performing Experiments
3. 3D Cell Culture Market Outlook - By Technology
3.1. Scaffold-Based
3.1.1. Hydrogels
3.1.2. Polymeric Scaffolds
3.1.3. Micropatterned Surface Microplates
3.2. Scaffold-Free
3.2.1. Hanging Drop Microplates
3.2.2. Spheroid Microplates Containing Ultra-Low Attachment (Ula) Coating
3.2.3. Microfluidic 3D Cell Culture
3.2.4. Magnetic Levitations & 3D Bioprinting
3.3. 3D Bioreactors
4. 3D Cell Culture Market Outlook - By Application
4.1. Cancer
4.2. Tissue Engineering & Immunohistochemistry
4.3. Drug Development
4.4. Stem Cell Research
4.5. Other Applications
5. 3D Cell Culture Market Outlook - By Component
5.1. Media
5.2. Reagents And Consumables
6. 3D Cell Culture Market Outlook - By End-User
6.1. Biotechnology And Pharmaceutical Organizations
6.2. Research Laboratories And Institutes
6.3. Hospitals And Diagnostic Centers
6.4. Other End-Users
7. 3D Cell Culture Market - Regional Outlook
7.1. Middle East And Africa
7.1.1. Country Analysis
7.1.1.1. Saudi Arabia
7.1.1.2. Turkey
7.1.1.3. United Arab Emirates
7.1.1.4. South Africa
7.1.1.5. Rest Of Middle East & Africa
8. Company Profiles
8.1. Becton Dickinson And Company
8.2. Tecan Group Ltd.
8.3. Promocell Gmbh
8.4. Corning Inc.
8.5. Nano3D Biosciences, Inc.
8.6. 3D Biotek, Llc
8.7. Merck Kgaa
8.8. Emulate
8.9. Thermo Fisher Scientific, Inc.
8.10. Ge Healthcare
8.11. Insphero
8.12. Lonza Group Ag
8.13. Vwr Corporation
8.14. Synthecon, Incorporated
For more information about this report visit https://www.researchandmarkets.com/r/3qr2wt
